Tenaya Therapeutics (TNYA) Revenue & Revenue Breakdown
Tenaya Therapeutics Revenue Highlights
0
Latest Revenue (Q)
$1.11M
Tenaya Therapeutics Revenue by Period
Tenaya Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Tenaya Therapeutics generated - in revenue during NA 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Tenaya Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $1.11M | 393.33% |
| 2026-03-31 | $225.00K | 100.00% |
| 2025-12-31 | - | 100.00% |
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Tenaya Therapeutics generated $1.11M in revenue during Q2 2026, up 393.33% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Tenaya Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ENTA | Enanta Pharmaceuticals | $65.32M | $14.36M |
| VYGR | Voyager Therapeutics | $40.37M | $3.17M |
| FHTX | Foghorn Therapeutics | $30.91M | $16.07M |
| PYXS | Pyxis Oncology | $13.86M | - |
| PRLD | Prelude Therapeutics | $12.14M | $5.70M |
| ABEO | Abeona Therapeutics | $5.82M | $11.38M |
| HUMA | Humacyte | $2.04M | $406.00K |
| IMRX | Immuneering | - | $360.96K |
| CRBU | Caribou Biosciences | - | - |
| TNYA | Tenaya Therapeutics | - | $1.11M |
| NAUT | Nautilus Biotechnolgy | - | $190.00K |